Global Edaravone Sales Market Report 2024
The global Edaravone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Edaravone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Oral Edaravone
Injection Edaravone
Segment by Application
Hospital
Clinic
Others
The Edaravone market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Edaravone market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
Table of Content
1 Edaravone Market Overview
1.1 Edaravone Product Scope
1.2 Edaravone Segment by Type
1.2.1 Global Edaravone Sales by Type (2016 & 2021 & 2027)
1.2.2 Oral Edaravone
1.2.3 Injection Edaravone
1.3 Edaravone Segment by Application
1.3.1 Global Edaravone Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Edaravone Market Estimates and Forecasts (2016-2027)
1.4.1 Global Edaravone Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Edaravone Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Edaravone Price Trends (2016-2027)
2 Edaravone Estimates and Forecasts by Region
2.1 Global Edaravone Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Edaravone Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Edaravone Sales Market Share by Region (2016-2021)
2.2.2 Global Edaravone Revenue Market Share by Region (2016-2021)
2.3 Global Edaravone Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Edaravone Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Edaravone Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Edaravone Estimates and Projections (2016-2027)
2.4.2 Europe Edaravone Estimates and Projections (2016-2027)
2.4.3 China Edaravone Estimates and Projections (2016-2027)
2.4.4 Japan Edaravone Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Edaravone Estimates and Projections (2016-2027)
2.4.6 India Edaravone Estimates and Projections (2016-2027)
3 Global Edaravone Competition Landscape by Players
3.1 Global Top Edaravone Players by Sales (2016-2021)
3.2 Global Top Edaravone Players by Revenue (2016-2021)
3.3 Global Edaravone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Edaravone as of 2020)
3.4 Global Edaravone Average Price by Company (2016-2021)
3.5 Manufacturers Edaravone Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Edaravone Market Size by Type
4.1 Global Edaravone Historic Market Review by Type (2016-2021)
4.1.1 Global Edaravone Sales Market Share by Type (2016-2021)
4.1.2 Global Edaravone Revenue Market Share by Type (2016-2021)
4.1.3 Global Edaravone Price by Type (2016-2021)
4.2 Global Edaravone Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Edaravone Sales Forecast by Type (2022-2027)
4.2.2 Global Edaravone Revenue Forecast by Type (2022-2027)
4.2.3 Global Edaravone Price Forecast by Type (2022-2027)
5 Global Edaravone Market Size by Application
5.1 Global Edaravone Historic Market Review by Application (2016-2021)
5.1.1 Global Edaravone Sales Market Share by Application (2016-2021)
5.1.2 Global Edaravone Revenue Market Share by Application (2016-2021)
5.1.3 Global Edaravone Price by Application (2016-2021)
5.2 Global Edaravone Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Edaravone Sales Forecast by Application (2022-2027)
5.2.2 Global Edaravone Revenue Forecast by Application (2022-2027)
5.2.3 Global Edaravone Price Forecast by Application (2022-2027)
6 North America Edaravone Market Facts & Figures
6.1 North America Edaravone Sales by Company
6.1.1 North America Edaravone Sales by Company (2016-2021)
6.1.2 North America Edaravone Revenue by Company (2016-2021)
6.2 North America Edaravone Sales Breakdown by Type
6.2.1 North America Edaravone Sales Breakdown by Type (2016-2021)
6.2.2 North America Edaravone Sales Breakdown by Type (2022-2027)
6.3 North America Edaravone Sales Breakdown by Application
6.3.1 North America Edaravone Sales Breakdown by Application (2016-2021)
6.3.2 North America Edaravone Sales Breakdown by Application (2022-2027)
7 Europe Edaravone Market Facts & Figures
7.1 Europe Edaravone Sales by Company
7.1.1 Europe Edaravone Sales by Company (2016-2021)
7.1.2 Europe Edaravone Revenue by Company (2016-2021)
7.2 Europe Edaravone Sales Breakdown by Type
7.2.1 Europe Edaravone Sales Breakdown by Type (2016-2021)
7.2.2 Europe Edaravone Sales Breakdown by Type (2022-2027)
7.3 Europe Edaravone Sales Breakdown by Application
7.3.1 Europe 120 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 120 Sales Breakdown by Application (2022-2027)
8 China Edaravone Market Facts & Figures
8.1 China Edaravone Sales by Company
8.1.1 China Edaravone Sales by Company (2016-2021)
8.1.2 China Edaravone Revenue by Company (2016-2021)
8.2 China Edaravone Sales Breakdown by Type
8.2.1 China Edaravone Sales Breakdown by Type (2016-2021)
8.2.2 China Edaravone Sales Breakdown by Type (2022-2027)
8.3 China Edaravone Sales Breakdown by Application
8.3.1 China 148 Sales Breakdown by Application (2016-2021)
8.3.2 China 148 Sales Breakdown by Application (2022-2027)
9 Japan Edaravone Market Facts & Figures
9.1 Japan Edaravone Sales by Company
9.1.1 Japan Edaravone Sales by Company (2016-2021)
9.1.2 Japan Edaravone Revenue by Company (2016-2021)
9.2 Japan Edaravone Sales Breakdown by Type
9.2.1 Japan Edaravone Sales Breakdown by Type (2016-2021)
9.2.2 Japan Edaravone Sales Breakdown by Type (2022-2027)
9.3 Japan Edaravone Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Edaravone Market Facts & Figures
10.1 Southeast Asia Edaravone Sales by Company
10.1.1 Southeast Asia Edaravone Sales by Company (2016-2021)
10.1.2 Southeast Asia Edaravone Revenue by Company (2016-2021)
10.2 Southeast Asia Edaravone Sales Breakdown by Type
10.2.1 Southeast Asia Edaravone Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Edaravone Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Edaravone Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Edaravone Market Facts & Figures
11.1 India Edaravone Sales by Company
11.1.1 India Edaravone Sales by Company (2016-2021)
11.1.2 India Edaravone Revenue by Company (2016-2021)
11.2 India Edaravone Sales Breakdown by Type
11.2.1 India Edaravone Sales Breakdown by Type (2016-2021)
11.2.2 India Edaravone Sales Breakdown by Type (2022-2027)
11.3 India Edaravone Sales Breakdown by Application
11.3.1 India Edaravone Sales Breakdown by Application (2016-2021)
11.3.2 India Edaravone Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Edaravone Business
12.1 Mitsubishi Tanabe Pharma
12.1.1 Mitsubishi Tanabe Pharma Corporation Information
12.1.2 Mitsubishi Tanabe Pharma Business Overview
12.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Mitsubishi Tanabe Pharma Edaravone Products Offered
12.1.5 Mitsubishi Tanabe Pharma Recent Development
12.2 Simcere
12.2.1 Simcere Corporation Information
12.2.2 Simcere Business Overview
12.2.3 Simcere Edaravone Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Simcere Edaravone Products Offered
12.2.5 Simcere Recent Development
12.3 Taj Pharmaceuticals Ltd.
12.3.1 Taj Pharmaceuticals Ltd. Corporation Information
12.3.2 Taj Pharmaceuticals Ltd. Business Overview
12.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Taj Pharmaceuticals Ltd. Edaravone Products Offered
12.3.5 Taj Pharmaceuticals Ltd. Recent Development
12.4 Sun Pharmaceutical Industries Ltd.
12.4.1 Sun Pharmaceutical Industries Ltd. Corporation Information
12.4.2 Sun Pharmaceutical Industries Ltd. Business Overview
12.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Products Offered
12.4.5 Sun Pharmaceutical Industries Ltd. Recent Development
12.5 Unichem Laboratories Ltd
12.5.1 Unichem Laboratories Ltd Corporation Information
12.5.2 Unichem Laboratories Ltd Business Overview
12.5.3 Unichem Laboratories Ltd Edaravone Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Unichem Laboratories Ltd Edaravone Products Offered
12.5.5 Unichem Laboratories Ltd Recent Development
12.6 UCB India Ltd
12.6.1 UCB India Ltd Corporation Information
12.6.2 UCB India Ltd Business Overview
12.6.3 UCB India Ltd Edaravone Sales, Revenue and Gross Margin (2016-2021)
12.6.4 UCB India Ltd Edaravone Products Offered
12.6.5 UCB India Ltd Recent Development
12.7 Piramal Healthcare
12.7.1 Piramal Healthcare Corporation Information
12.7.2 Piramal Healthcare Business Overview
12.7.3 Piramal Healthcare Edaravone Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Piramal Healthcare Edaravone Products Offered
12.7.5 Piramal Healthcare Recent Development
...
13 Edaravone Manufacturing Cost Analysis
13.1 Edaravone Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Edaravone
13.4 Edaravone Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Edaravone Distributors List
14.3 Edaravone Customers
15 Market Dynamics
15.1 Edaravone Market Trends
15.2 Edaravone Drivers
15.3 Edaravone Market Challenges
15.4 Edaravone Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer